title: How far have we come with solid (nonhematologic) tumor radioimmunotherapy?
authors.affiliation: Virginia Mason Medical Center, Seattle, Washington 98101, USA.
authors.forename: H B
authors.initials: HB
authors.lastname: Breitz
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D002294:Carcinoma, Squamous Cell / Q000532:radiotherapy; D006258:Head and Neck Neoplasms / Q000532:radiotherapy; D006801:Humans; D009369:Neoplasms / Q000532:radiotherapy*; D016499:Radioimmunotherapy; D011868:Radioisotopes / Q000627:therapeutic use; D011879:Radiotherapy Dosage; D011993:Recombinant Fusion Proteins; D012211:Rhenium / Q000627:therapeutic use
chemical_list: D000911:Antibodies, Monoclonal; D011868:Radioisotopes; D011993:Recombinant Fusion Proteins; D012211:Rhenium